WHO and UK trials use potentially lethal hydroxychloroquine dose-according to WHO consultant
India’s ICMR, its official medical research agency, had written to the WHO, telling WHO that the hydroxychloroquine doses being used in the Solidarity trial were 4 times higher than the doses being used in India.